Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Endo
Pharma
Endo CEO departs after company emerges from Chapter 11
Four months after emerging from bankruptcy, Endo Pharmaceuticals is in transition again with the sudden departure of CEO Blaise Coleman.
Kevin Dunleavy
Aug 27, 2024 1:55pm
Endo takes a hands-on approach to new Dupuytren's contracture ad
Jun 10, 2024 3:11pm
Endo agrees to bankruptcy settlement with federal government
Feb 29, 2024 3:11pm
Endo hits Zydus with patent suit over generic version of Chantix
Aug 11, 2023 10:45am
Price hikes for 5 Pfizer drugs outpaced inflation in Q4: HHS
Mar 15, 2023 10:48am
Endo launches new DTC campaign to set men straight
Feb 6, 2023 10:17am
